TORONTO, July 05, 2018 (GLOBE NEWSWIRE) -- Maricann Group Inc. (CSE:MARI)(FRANKFURT:75M)(OTCQB:MRRCF)
(“Maricann” or the “Company”) Further to our corporate update earlier today, Maricann is pleased to announce that they have entered
into an agreement with the Alberta Gaming, Liquor & Cannabis Commission (AGLC) to allocate up to 3,375 kg of cannabis product for
the AB market within the first six months.
“Alberta is a strategic market for further developing our portfolio of Recreational brands. We congratulate the
work the AGLC has done getting ready for October 17, 2018 to responsibly provide Cannabis to Albertans.” Geoff Kosar, Vice
President Sales and Marketing.
About Maricann Group Inc.
Maricann is a vertically integrated producer and distributor of marijuana for medical purposes. The company was
founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario
where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from
the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland.
Maricann is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq.
m) build-out and will continue to pursue new opportunities in Europe.
Forward Looking Statements
Certain statements in this press release contain forward-looking statements, including, without limitation
with respect to (i) the execution of additional supply agreements, (ii) anticipated production at the Langton Facility, (iii)
receipt of regulatory approvals in German, (iv) the entering into of one or more strategic transactions, which can be identified by
the use of forward-looking terminology such as “believes”, “expects”, “may”, “desires”, “will”, “should”, “projects”, “estimates”,
“contemplates”, “anticipates”, “intends”, or any negative such as “does not believe” or other variations thereof or comparable
terminology. No assurance can be given that potential future results or circumstances described in the forward-looking statements
will be achieved or will occur. By their nature, these forward-looking statements, necessarily involve risks and uncertainties,
including those discussed herein, that could cause actual results to significantly differ from those contemplated by these
forward-looking statements. Such statements reflect the view of the Company with respect to future events, and are based on
information currently available to the Company and on assumptions, which it considers reasonable. Management cautions readers that
the assumptions relative to the future events, several of which are beyond management’s control, could prove to be incorrect, given
that they are subject to certain risk and uncertainties, and that actual results may differ materially from those projected.
Factors which could cause results or events to differ from current expectations include, among other things: risks inherent to the
expansion project; fluctuations in operating results; the impact of general economic, industry and market conditions; the ability
to recruit and retain qualified employees; fluctuations in cash flow; increased levels of outstanding debt and obligations under a
capital lease; expectations regarding market demand for particular products and the dependence on new product development; the
impact of market change; and the impact of price and product competition, the ability to secured applicable licenses as well as
other risks discussed in its latest annual information form and other disclosure documents of the Company available at
www.sedar.com. Management disclaims any intention or obligation to update or revise any forward-looking statements whether as a
result of new information, future events or otherwise, except as required by applicable securities laws. The reader is cautioned
not to place undue reliance on forward-looking information.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news
release.
For more information about Maricann, please visit our website at www.maricann.com
CONTACT INFORMATION
Investor Relations
Graham Farrell
Director of Investor Relations
graham@maricann.com
647-643-7665
Corporate Headquarters (Canada)
Maricann Group Inc. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
Canada
289-288-6274
European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen, Deutschland
